Who owns BBOT?
Institutional ownership of BridgeBio Oncology Therapeutics Inc. from Form 13F, Q2 2026
66 institutional managers reported holding BridgeBio Oncology Therapeutics Inc. (BBOT) in Form 13F filings for Q2 2026, with 59,128,852 shares worth $451M. The largest reported holder was Cormorant Asset Management, LP. Managers that filed both quarters added a net 1,649,811 shares (+2.9%). 17 opened new positions and 18 sold out.
- Funds holding
- 66
- Value held
- $451M
- New / sold out
- 17 / 18
- Net shares, same filers
- +2.9%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of BBOT
Share of 13F holdings is each fund's shares as a share of the 59,128,852 BBOT shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- Vanguard Capital Management LLC Added+$11.2M
- State Street Corp Added+$6.2M
- Opaleye Management Inc. Added+$4.9M
- Sphera Funds Management LTD. New+$3.5M
- Armistice Capital, LLC Added+$3.3M
- Granahan Investment Management, LLC Added+$2.5M
- Catalio Capital Management, LP New+$2.4M
- BNP Paribas Financial Markets Added+$765K
- Citadel Advisors LLC Added+$679K
- Palumbo Wealth Management LLC New+$652K
Biggest sellers in Q2 2026
- Paradigm Biocapital Advisors LP Sold out-$7.8M
- Octagon Capital Advisors LP Sold out-$6.4M
- Eventide Asset Management, LLC Sold out-$4.7M
- Ikarian Capital, LLC Sold out-$2.4M
- Royce & Associates LP Trimmed-$1.9M
- Millennium Management LLC Trimmed-$1.2M
- Price T Rowe Associates Inc Trimmed-$1.1M
- Hudson Bay Capital Management LP Sold out-$985K
- Woodline Partners LP Sold out-$928K
- Boothbay Fund Management, LLC Sold out-$724K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $42.4M and sold $33.7M; 21 added and 15 trimmed.
Schedule 13D and 13G filings on BBOT
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2025-08-18Flynn James E SCHEDULE 13G filed by Helix Acquisition Corp. IISchedule 13G
- 2025-07-25Sculptor Capital LP SCHEDULE 13G filed by Helix Acquisition Corp. IISchedule 13G
- 2025-04-15BlackRock Portfolio Management LLC SCHEDULE 13G filed by Helix Acquisition Corp. IISchedule 13G
Questions about BBOT ownership
- Who owns BBOT stock?
- 66 institutional investment managers reported BBOT positions in their Form 13F filings for Q2 2026, holding 59,128,852 shares worth $451M in total. Cormorant Asset Management, LP reported the largest position.
- Are funds buying or selling BBOT?
- In Q2 2026, 17 managers opened new BBOT positions, 21 added, 15 trimmed and 18 sold out. Managers that filed in both quarters added a net 1,649,811 shares.
- How current is this BBOT institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to BBOT by CUSIP. Options are left out. BBOT news and filings · BBOT insider trades · Top funds